Source: BEFREE

Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1805192
rs1805192
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs1805192
rs1805192
CUI: C0011847
Disease: Diabetes
Diabetes
0.100 GeneticVariation BEFREE Diabetes genomics research has illuminated single nucleotide polymorphism (SNP) in several genes including, fat mass and obesity associated (FTO) (rs9939609 and rs9926289), potassium voltage-gated channel subfamily J member 11 (rs5219), SLC30A 8 (rs13266634) and peroxisome proliferator-activated receptor gamma 2 (rs1805192). 31823921

2019

dbSNP: rs1805192
rs1805192
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 GeneticVariation BEFREE Genotyping for Pro12Ala and Trp64Arg polymorphism in postmenopausal women may have the clinical benefit of predicting hyperglycaemia, thereby contributing to the prevention of diabetes mellitus development in the future. 29464546

2018

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Albeit small, our study may suggest that other pathways in AT or effects exerted in other tissues might contribute to the Pro12Ala-mediated protection against T2D. 30064293

2018

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE In addition, the impact of total energy intake on obesity in Pro12Ala</span> carriers seemed to be stronger than that in the wild-type genotype carriers. 30122193

2018

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Our results support an important association between rs1805192 and rs3856806 minor allele (G allele) of PPARG and increased T2DM risk, the interaction analysis shown a combined effect of G- obesity interaction between rs1805192 and obesity on increased T2DM risk. 28123453

2017

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE Our results support an important association between rs1805192 and rs3856806 minor allele (G allele) of PPARG and increased T2DM risk, the interaction analysis shown a combined effect of G- obesity interaction between rs1805192 and obesity on increased T2DM risk. 28123453

2017

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE We found a significant association of Pro12Ala polymorphism of PPARγ2 gene with T2DM, however the genotypes showed statistically significant association only with few clinical parameters including body mass index, total cholesterol, and low-density lipoprotein (P < 0.05). 27567620

2017

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE These findings suggest no significant association of p.Pro12Ala polymorphism with retinopathy in tested type 2 diabetic retinopathy patients as compared to T2DM individuals take as controls. 27427939

2017

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE Our results support an important association between rs1805192 minor allele (G allele) of PPARG and increased DN risk; the interaction analysis showed a combined effect of interaction between rs1805192 and abdominal obesity on DN risk. 28013303

2017

dbSNP: rs1805192
rs1805192
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.100 GeneticVariation BEFREE Polymorphism in rs10865710, rs1805192 and rs4646903 and interaction between rs1805192 and rs4646903 were related with increased CAD susceptibility. 28415751

2017

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE The measured parameters for mothers and their newborns were risk percentage for child obesity, anthropometric characteristics (mid-upper arm circumference [MUAC], tricipital skinfold thickness [TST] of mother and newborn), genetic polymorphisms (human peroxisome proliferator-activated receptor γ [PPARγ2] 34 C > G and transforming growth factor-beta 1 [TGF-β1] 869 T > C gene polymorphisms in both mothers and newborns), and mother's bioimpedance characteristics (fat mass [FM] %).The obesity risk score according to standard predictable Northern Finland Birth Cohort equation was in our study 4.07%. 27442659

2016

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE The aim of this study was to investigate the relationship between functional polymorphisms Gly482Ser in PPARGC1A and Pro12Ala in PPARG2 with the presence of obesity and metabolic risk factors. 26185753

2015

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes. 25974167

2015

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE We genotyped PPARγ Pro12Ala polymorphism in subjects with type 2 diabetes mellitus (T2DM). 26836268

2015

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population. 25182148

2015

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE Obesity and Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor-Gamma Gene in Healthy Adults: A Systematic Review and Meta-Analysis. 26361038

2015

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Variation in PPARG, but not Pro12Ala, contributes to declining SI and concomitant deterioration in β-cell function in Mexican Americans at risk for T2DM. 25584717

2015

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE The combined results showed that PPAR-γ Pro1</span>2Ala polymorphism was associated with the obesit</span>y risk (Ala vs. 25502405

2015

dbSNP: rs1805192
rs1805192
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.100 GeneticVariation BEFREE Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa. 24447396

2014

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE In the group with ACE DD genotype, those with PPARγ Pro12Ala or Ala12Ala genotype have greater odds for obesity (OR=9.98; 95% CI: 1.18-84.14, p=0.034). 24200052

2014

dbSNP: rs1805192
rs1805192
CUI: C0028754
Disease: Obesity
Obesity
0.100 GeneticVariation BEFREE The single nucleotide polymorphisms (SNPs) of the above genes, such as GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala, are associated with obesity and body mass index. 24827746

2014

dbSNP: rs1805192
rs1805192
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE In rare families, loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy and insulin resistance; in the general population, the common P12A variant is associated with a decreased risk of type 2 diabetes (T2D). 25157153

2014

dbSNP: rs1805192
rs1805192
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation BEFREE In the group of participants with PPARγ Pro12Ala or Ala12Ala genotypes, those with the LPL Pvu (-/+) or (+/+) genotype had greater odds for MetSy (odds ratio OR=5.98; 95% confidence interval CI: 1.46-24.47, p=0.013). 24200052

2014

dbSNP: rs1805192
rs1805192
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.100 GeneticVariation BEFREE This study suggests that the PPARγ C1431T polymorphism is related to an increased risk of MetS in an Iranian population and interacts with the Pro12Ala polymorphism, further increasing the risk of MetS. 24464185

2014